Want to see HK:6618 full AI Analyst Report?

JD Health International, Inc. (6618) Price & Analysis

23 Followers

6618 Stock Chart & Stats

HK$37.00

HK$0.78(2.11%)

At close: Jul 27 4:00 PM EDT

HK$37.00

HK$0.78(2.11%)

Day’s Range― - ―

52-Week RangeHK$31.84 - HK$71.70

Previous CloseN/A

Volume4.55M

Average Volume (3M)7.60M

Market Cap

HK$126.05B

Enterprise ValueHK$51.43K

Total Cash (Recent Filing)HK$48.15B

Total Debt (Recent Filing)HK$636.29M

Price to Earnings (P/E)20.2

Beta1.39

Next Earnings

Mar 29, 2027

EPS Estimate

1.08

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.68

Shares Outstanding3,189,531,000

10 Day Avg. Volume6,883,323

30 Day Avg. Volume7,596,953

Financial Highlights & Ratios

PEG Ratio1.02

Price to Book (P/B)2.65

Price to Sales (P/S)2.17

P/FCF Ratio16.35

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$67.02

Price Target Upside81.14% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

EPS Forecast (FY)1.81

Revenue Forecast (FY)HK$86.34B

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthThe company’s very low leverage and meaningful equity growth, with ROE improving to ~8.7% in 2025, provide durable financial flexibility. A conservative capital structure supports continued investment in supply chain, AI and measured offline expansion while limiting solvency and refinancing risk.

Sustained Revenue & Profit GrowthConsistent double‑digit top‑line growth and outsized non‑IFRS profit improvement demonstrate durable scale advantages. Repeated quarter growth and margin expansion suggest sustainable operating leverage, enabling reinvestment into R&D, supply chain and service expansion over the medium term.

Product, AI And Supply‑chain ScaleRobust product-launch capability plus high AI engagement and a growing clinical footprint create structural advantages. Large-scale drug launches, clinical partnerships and AI interactions build proprietary data, deepen customer relationships and strengthen the supply‑chain moat if commercialization continues to progress.

Bears Say

Free Cash Flow InconsistencyA 2025 FCF reset to zero despite solid operating cash flow signals a step-up in capex or working-capital demands. Uneven cash conversion versus earnings reduces near‑term financial optionality for buybacks, acquisitions or accelerated store expansion until free cash flow normalizes.

Revenue Concentration In Direct SalesWith ~83% of revenue from direct sales, the business is exposed to category, supplier and pricing shifts. High concentration raises execution risk: sustained growth requires either continued dominance in those categories or successful diversification into higher‑margin service and insurance channels.

AI Monetization & Offline Economics UncertaintyHigh engagement with AI and cautious offline expansion are strategic strengths but lack clear monetization timelines. Continued investment in AI products and S&M, alongside lower‑margin offline stores, could compress margins and delay ROIC improvements until commercial paths are proven.

JD Health International, Inc. News

JD Health Earnings Call Highlights Profits, AI Push

JD Health International, Inc. (($HK:6618)) has held its Q2 earnings call. Read on for the main highlights of...

2d ago

6618

JD Health Boosts Profitability on Policy-Backed Healthcare and AI Expansion

JD Health International, Inc. ( ($HK:6618) ) has issued an update. JD Health reported interim results for the...

2d ago

6618

JD Health Sets August 13 Board Meeting to Approve Interim Results

JD Health International, Inc. ( ($HK:6618) ) has provided an update. JD Health International Inc. has scheduled a...

15d ago

6618

JD Health Shareholders Approve All Resolutions at 2026 AGM

An announcement from JD Health International, Inc. ( ($HK:6618) ) is now available. JD Health International Inc., a...

2M ago

6618

JD Health Restructures VIE Shareholding While Keeping HKEX Waiver Intact

JD Health International, Inc. ( ($HK:6618) ) just unveiled an update. JD Health International has restructured the ownership...

2M ago

6618

JD Health Sets 2026 AGM to Approve Results and Renew Capital-Issuance Mandate

JD Health International, Inc. ( ($HK:6618) ) has provided an announcement. JD Health International has called its annual...

2M ago

6618

JD Health Unveils US$1 Billion Share Buyback to Signal Confidence and Support Valuation

JD Health International, Inc. ( ($HK:6618) ) has issued an update. JD Health International Inc. has launched a...

3M ago

6618

JD Health Posts Strong Q1 2026 Growth, Expands AI-Driven Healthcare and Sets Up Share Incentive Trust

JD Health International, Inc. ( ($HK:6618) ) has issued an update. JD Health International reported strong unaudited results...

3M ago

6618

JD Health Grants New Employee Share Awards With Tight Clawback Terms

JD Health International, Inc. ( ($HK:6618) ) has issued an update. JD Health International has granted 834,412 new...

5M ago

6618

JD Health Revamps Suqian Tianning Shareholding While Preserving IPO Waiver

JD Health International, Inc. ( ($HK:6618) ) has shared an announcement. JD Health International Inc. has restructured the...

5M ago

6618

6618 FAQ

What was JD Health International, Inc.’s price range in the past 12 months?

JD Health International, Inc. lowest stock price was HK$31.84 and its highest was HK$71.70 in the past 12 months.

What is JD Health International, Inc.’s market cap?

JD Health International, Inc.’s market cap is HK$126.05B.

When is JD Health International, Inc.’s upcoming earnings report date?

JD Health International, Inc.’s upcoming earnings report date is Mar 29, 2027 which is in 226 days.

How were JD Health International, Inc.’s earnings last quarter?

JD Health International, Inc. released its earnings results on Aug 13, 2026. The company reported HK$1.245 earnings per share for the quarter, missing the consensus estimate of HK$1.362 by -HK$0.116.

Is JD Health International, Inc. overvalued?

According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does JD Health International, Inc. pay dividends?

JD Health International, Inc. does not currently pay dividends.

What is JD Health International, Inc.’s EPS estimate?

JD Health International, Inc.’s EPS estimate is 1.08.

How many shares outstanding does JD Health International, Inc. have?

JD Health International, Inc. has 3,189,531,000 shares outstanding.

What happened to JD Health International, Inc.’s price movement after its last earnings report?

JD Health International, Inc. reported an EPS of HK$1.245 in its last earnings report, missing expectations of HK$1.362. Following the earnings report the stock price went up 1.698%.

Which hedge fund is a major shareholder of JD Health International, Inc.?

Currently, no hedge funds are holding shares in HK:6618

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

JD Health International, Inc. Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

13.17%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

JD Health International, Inc.

JD Health International Inc., functioning as an investment holding entity, runs an expansive digital healthcare platform across the People's Republic of China. The company supplies a diverse range of pharmaceutical and wellness products, such as over-the-counter and prescription medications, medical devices, and health supplements. These goods are distributed through both direct sales and an extensive online retail pharmacy network. Beyond product offerings, its comprehensive service suite includes virtual medical consultations, patient referrals to hospitals and doctors, health screening programs, genetic testing, and beauty care services. Additionally, it develops intelligent healthcare and wellness management solutions, alongside providing technical support and advertising services. The platform also facilitates access to various medical provisions, including general health examinations, cosmetic medical procedures, vaccination bookings, dental treatments, and nucleic acid testing. Incorporated in 2018 and headquartered in Beijing, People's Republic of China, JD Health International Inc. is a subsidiary of JD Jiankang Limited.

JD Health International, Inc. (6618) Earnings & Revenues

Historic Earnings Reports

6618 Stock 12 Month Forecast

Average Price Target

HK$67.02

▲(81.14% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"31":"HK$31","42":"HK$42","53":"HK$53","64":"HK$64","75":"HK$75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":74,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$74.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":67.02,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$67.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":61.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$61.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[31,42,53,64,75],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.4,42.06153846153846,44.723076923076924,47.38461538461539,50.04615384615384,52.70769230769231,55.36923076923077,58.03076923076923,60.69230769230769,63.353846153846156,66.01538461538462,68.67692307692307,71.33846153846154,{"y":74,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.4,41.52461538461538,43.64923076923077,45.77384615384615,47.89846153846153,50.02307692307692,52.1476923076923,54.27230769230769,56.39692307692307,58.521538461538455,60.646153846153844,62.770769230769226,64.89538461538461,{"y":67.02,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,39.4,41.13076923076923,42.86153846153846,44.59230769230769,46.323076923076925,48.05384615384615,49.784615384615385,51.51538461538462,53.246153846153845,54.97692307692307,56.707692307692305,58.43846153846154,60.169230769230765,{"y":61.9,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":48.75,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.7,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.95,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.64,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.36,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.12,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.84,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.4,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >